Novartis

First-ever licencing deal struck for cancer drug

The deal will give selected manufacturers the opportunity to develop, manufacture and supply generic versions of nilotinib, a twice-daily oral medication used to treat chronic myeloid leukaemia.

published on : 20th October 2022

Swiss pharma company gives Rs 16-crore drug free to save 23-month-old Hyderabad baby

Novartis, the Switzerland-based pharmaceutical firm, supplied the drug-free of cost for Ellen, daughter of Rayapudi Praveen and Stella, residents of Reguballi village in Bhadradri Kothagudem district.

published on : 8th August 2022

Pharma giant Novartis slashes 8,000 jobs worldwide, some jobs to be transferred to India

The company aims to "rationalise our global functions", a Novartis spokesman told AFP, adding that jobs in finance, legal services and communications would be cut.

published on : 29th June 2022